HIV Protease InhibitorsNelfinavirRitonavirHIV ProteaseIndinavirSaquinavirLopinavirPyrimidinonesProtease InhibitorsCarbamatesHIV InfectionsDrug InteractionsSulfonamidesAnti-HIV AgentsArea Under CurveOligopeptidesPyridinesSerine Proteinase InhibitorsHIV-1HIVHalf-LifeCytochrome P-450 CYP3AP-GlycoproteinDose-Response Relationship, DrugOrganic Cation Transporter 1Chromatography, High Pressure LiquidAntiretroviral Therapy, Highly ActiveBiological AvailabilitySerine EndopeptidasesCells, CulturedPeptide HydrolasesDrug Resistance, ViralSecretory Leukocyte Peptidase InhibitorMetabolic Clearance RateAdipocytesPharmacokineticsGlucose Transporter Type 4Administration, OralEndopeptidasesPepstatinsMolecular Sequence DataAmino Acid SequenceHIV SeropositivityCell LineCytochrome P-450 Enzyme SystemMultidrug Resistance-Associated ProteinsProteinase Inhibitory Proteins, SecretoryTrypsin InhibitorsApoptosisSerpinsCysteine ProteasesReverse Transcriptase InhibitorsDeoxyglucoseMolecular StructureCaspasesCysteine EndopeptidasesMicrosomes, LiverInjections, IntravenousCysteine Proteinase InhibitorsKineticsProtease NexinsLiverBiological TransportProto-Oncogene Proteins c-aktalpha 1-AntitrypsinAspartic Acid EndopeptidasesAprotininInsulin ResistanceProtease LaTissue DistributionModels, MolecularPyronesCell Line, TumorDrug DesignLipodystrophySubstrate SpecificityGlucoseTosyllysine Chloromethyl KetoneGabexateInfusions, IntravenousCross-Over StudiesDidanosineRecombinant ProteinsATP-Dependent ProteasesProtein BindingRNA, MessengerMutationTrypsin Inhibitor, Bowman-Birk SoybeanMice, Inbred C57BLInsulinDrug Administration ScheduleZidovudineSignal TransductionHIV SeronegativityAntipainCathepsins